Quick Answer
Bluejay Diagnostics, Inc. reported Earnings Per Share Diluted of $15.25 (loss) per share for the year ending 2025.
- Bluejay Diagnostics, Inc. showed an increase of +96.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Bluejay Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.15 (loss) per share | Q3 2021: $0.11 (loss) per share | Q1 2022: $0.10 (loss) per share | Q2 2022: $2.00 (loss) per share | Q3 2022: $2.94 (loss) per share | Q1 2023: $2.49 (loss) per share | Q2 2023: $22.00 (loss) per share | Q3 2023: $16.67 (loss) per share | Q1 2024: $394.76 (loss) per share | Q2 2024: $256.16 (loss) per share | Q3 2024: $76.94 (loss) per share | Q1 2025: $3.37 (loss) per share | Q2 2025: $1.41 (loss) per share | Q3 2025: $1.01 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Bluejay Diagnostics, Inc.'s Earnings Per Share Diluted has declined by 3,619.5%.
- Historical annual values: Fiscal year 2025: $15.25 (loss) per share | Fiscal year 2024: $456.75 (loss) per share | Fiscal year 2023: $3,631.48 (loss) per share | Fiscal year 2022: $9.22 (loss) per share | Fiscal year 2021: $0.41 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: